We have also identified and validated Alzheimer’s disease specific markers ectonucleotide pyrophosphatase/phosphodiesterase 2, lysosome-associated membrane protein 1, pro-orexin and transthyretin that have the potential to discriminate Lewy body dementia from Alzheimer’s disease. Here, PDE12 is linked to Lewy body dementia.